Clinical Trials Logo

Clinical Trial Details — Status: Not yet recruiting

Administrative data

NCT number NCT05886166
Other study ID # HangangSHH-16
Secondary ID
Status Not yet recruiting
Phase N/A
First received
Last updated
Start date June 15, 2023
Est. completion date December 31, 2023

Study information

Verified date May 2023
Source Hangang Sacred Heart Hospital
Contact Baek Seongeun
Phone 82-2-2639-5900
Email tjddms1108@hallym.or.kr
Is FDA regulated No
Health authority
Study type Interventional

Clinical Trial Summary

Bone and/or joint infections, such as septic arthritis (SA), are rare, but delayed diagnosis or improper treatment can result in irreversible joint destruction. Therefore, early diagnosis and effective treatment are necessary to prevent severe outcomes. Clear protocols for SA rehabilitation are unavailable, and physiotherapy studies are few. Robot training in patients with musculoskeletal diseases, including burns, can reduce pain and improve lower extremity function. Studies on robot training have been conducted in patients with burn injuries. Rebless® (H-ROBOTICS, KOREA) is a knee or ankle robot for range of motion (ROM) and strength training that can operate in passive or active mode in knee or ankle flexion and extension. The patients underwent 30 min of robot training using Rebless® with 30 min conventional therapy, 5 days a week for 8 weeks. This study aims to confirm the clinical effect after 8 weeks of robotic treatment for patients diagnosed with septic arthritis.


Description:

Bone and/or joint infections, such as septic arthritis (SA), are rare, but delayed diagnosis or improper treatment can result in irreversible joint destruction. Therefore, early diagnosis and effective treatment are necessary to prevent severe outcomes. Clear protocols for SA rehabilitation are unavailable, and physiotherapy studies are few. Robot training in patients with musculoskeletal diseases, including burns, can reduce pain and improve lower extremity function. Studies on robot training have been conducted in patients with burn injuries. Rebless® (H-ROBOTICS, KOREA) is a knee or ankle robot for range of motion (ROM) and strength training that can operate in passive or active mode in knee or ankle flexion and extension. Patients who underwent split thickness skin graft (STSG) at Hangang Sacred Heart Hospital, diagnosed with septic arthritis, aged >18 years, when weight bearing is not possible during intravenous antibiotic treatment in this study. This study excluded patients who had musculoskeletal diseases (fracture, amputation, rheumatoid arthritis, and degenerative joint diseases) involving the burned lower extremity. Patients with cognitive disorders, intellectual impairment before burn injury, serious cardiac dysfunction, problems with body weight ≥100 kg due to the belt length for fixing the thigh and calf, severe fixed contracture, skin disorders that could be worsened by RAGT, and severe pain who were unable to undergo rehabilitation programs were excluded. The patients underwent 30 min of robot training using Rebless® with 30 min conventional therapy, 5 days a week for 8 weeks. This study aims to confirm the clinical effect after 8 weeks of robotic treatment for patients diagnosed with septic arthritis.


Recruitment information / eligibility

Status Not yet recruiting
Enrollment 2
Est. completion date December 31, 2023
Est. primary completion date December 25, 2023
Accepts healthy volunteers No
Gender All
Age group 18 Years to 75 Years
Eligibility Inclusion Criteria: - diagnosed with septic arthritis - aged >18 years, < 75 years - when weight bearing is not possible during intravenous antibiotic treatment in this study. Exclusion Criteria: - had musculoskeletal diseases (fracture, amputation, rheumatoid arthritis, and degenerative joint diseases) - cognitive disorders - intellectual impairment before burn injury - serious cardiac dysfunction - skin disorders that could be worsened by robot training

Study Design


Intervention

Other:
robot assisted training
Rebless® (H-ROBOTICS, KOREA) is a knee or ankle robot for range of motion (ROM) and strength training that can operate in passive or active mode in knee or ankle flexion and extension. The patients underwent 30 min of robot training using Rebless® with 30 min conventional therapy, 5 days a week for 8 weeks.

Locations

Country Name City State
n/a

Sponsors (1)

Lead Sponsor Collaborator
Hangang Sacred Heart Hospital

References & Publications (3)

Barret JP, Desai MH, Herndon DN. Osteomyelitis in burn patients requiring skeletal fixation. Burns. 2000 Aug;26(5):487-9. doi: 10.1016/s0305-4179(99)00182-5. — View Citation

Couderc M, Bart G, Coiffier G, Godot S, Seror R, Ziza JM, Coquerelle P, Darrieutort-Laffite C, Lormeau C, Salliot C, Veillard E, Bernard L, Baldeyrou M, Bauer T, Hyem B, Touitou R, Fouquet B, Mulleman D, Flipo RM, Guggenbuhl P; French Rheumatology Society — View Citation

Ju F, Wang Y, Xie B, Mi Y, Zhao M, Cao J. The Use of Sports Rehabilitation Robotics to Assist in the Recovery of Physical Abilities in Elderly Patients with Degenerative Diseases: A Literature Review. Healthcare (Basel). 2023 Jan 21;11(3):326. doi: 10.339 — View Citation

Outcome

Type Measure Description Time frame Safety issue
Primary Functional ambulatory category (FAC) 6-point scale: 0, the patient could not walk or could only walk with the assistance of two people and 5, the patient can walk independently. 8 weeks
Secondary 6-min walking test (6 MWT) distance 6MWT measures the maximum distance a participant can walk in 6 min on a 20 m flat surface. 8 weeks
Secondary visual analog scale (VAS) The visual analog scale (VAS) is used to assess subjective pain, with 0 representing no pain and 10 representing unbearable pain. 8 weeks
Secondary Isometric muscle strength Isometric muscle strength (hip, knee, and ankle) was measured using a microFET IITM (Hoggan Health Industries, Draper, UT, USA). Each trial lasted for 3-5 s, with a 30-s rest period between trials 8weeks
Secondary range of motion (ROM) The highest values obtained from the two valid measurements were recorded. The active ROMs of different joints (hip, knee, and ankle) were measured using a goniometer following a standardized technique. 8 weeks
See also
  Status Clinical Trial Phase
Not yet recruiting NCT06003374 - Extended Hip Ultrasound as Anew Protocol for Septic Hip in Children
Active, not recruiting NCT04563325 - Oral-only Antibiotics for Bone and Joint Infections in Children Phase 4
Completed NCT05341908 - Prevalence of Pathogens in Synovial Fluid Obtained From Emergency Department Patients
Completed NCT03846804 - Next-Generation Sequencing for Pathogen Detection and Quantification in Children With Musculoskeletal Infections N/A
Completed NCT00503438 - Ankle Joint Replacement Outcomes Study
Recruiting NCT04952220 - Exploratory Study of Ultrasound Signs of Native Septic Arthritis of the Knee
Active, not recruiting NCT02565160 - Analysis of Human Knee Joint Fluid Using Metabonomic, Genomic and Tribology Techniques
Recruiting NCT05971745 - Accuracy of Pediatric Emergency Medicine Providers in Diagnosing Hip Effusions Using Point of Care Ultrasound
Completed NCT05593874 - Predictive Value of Nu.Q™ Biomarkers to Help Guiding the Management of Osteoarticular Infections
Recruiting NCT02530229 - Arthrocentesis Study N/A
Not yet recruiting NCT05521880 - Anchoring Sequential Intermittent Long Acting Antimicrobials With Medication for Opioid Use Disorder (MOUD) for Invasive Infections Related to Opioid Use Phase 4
Completed NCT03802552 - Cefadroxil and Cephalexin Drug Levels and Dosing in Pediatric Musculoskeletal Infections Phase 1
Not yet recruiting NCT05780697 - Short Term Results of Pediatric Septic Hip Arthritis Management in Assiut University Hospitals N/A
Recruiting NCT03704766 - Alpha-Defensin and Synovial Proteins to Improve Detection of Pediatric Septic Arthritis N/A
Recruiting NCT04538053 - BonE and Joint Infections - Simplifying Treatment in Children Trial Phase 4
Recruiting NCT04141787 - Ceftriaxone as Home IV for Staph Infections Phase 4
Completed NCT06241365 - The Predictive Role of C-reactive Protein to Albumin Ratio (CAR) in the Treatment of Septic Arthritis in Young Chlidren
Completed NCT03426761 - Dalbavancin For The Treatment of Gram Positive Osteoarticular Infections Phase 4
Completed NCT02018952 - Ultrasonography Assessment of Septic Arthritis on Native Joint N/A
Recruiting NCT04284423 - Study of Synovial Lactate Level as Marker of Septic Arthritis